SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VII. Lyon, IARC: IARC Sci. Publ. No. 143, 1997.
  • 2
    Negri E, Ron E, Franceschi S, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control 1999;10: 13142.
  • 3
    Negri E, Dal Maso L, Ron E, et al. 1999. A pooled analysis of case-control studies of thyroid cancer II. Menstrual and reproductive factors. Cancer Causes Control 1999;10: 14355.
  • 4
    La Vecchia C, Ron E, Franceschi S, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999;10: 15766.
  • 5
    Franceschi S, Boyle P, Maisonneuve P, et al. The epidemiology of thyroid carcinoma. Crit Rev Oncog 1993;4: 2552.
  • 6
    Salabe GB. Etiology of thyroid cancer: an epidemiological overview. Thyroidology Clin Exp 1994;6: 119.
  • 7
    Ron E. Epidemiology of thyroid cancer. In: SchottenfeldD, FraumeniJRJr, eds. Cancer epidemiology and prevention, 2nd ed. Oxford: Oxford University Press, 1996. 100021.
  • 8
    Mack WJ, Preston-Martin S. Epidemiology of thyroid cancer. In: FaginJA, ed. Thyroid cancer. USA: Kluwer Academic Publishers, 1998. 125.
  • 9
    Pacchiarotti A, Martino E, Bartalena L, et al. Serum thyrotropin by ultrasensitive immunoradiometric assay and serum free thyroid hormones in pregnancy. J Endocrinol Invest 1986;9: 1859.
  • 10
    Williams ED. TSH and thyroid cancer. Horm Metab Res Suppl 1990; 23: 725.
  • 11
    Malkasian GD, Mayberry WE. Serum total and free thyroxine and thyrotropin in normal and pregnant women, neonates and women receiving progestogens. Am J Obstet Gynecol 1970;108: 12348.
  • 12
    Rastogi GK, Sawhney RC, Sinha MK, et al. Serum and urinary levels of thyroid hormones in normal pregnancy. Obstet Gynecol 1974;44: 17680.
  • 13
    Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev 1993;14: 194202.
  • 14
    Mann K, Hoermann R. Thyroid stimulation by placental factors. J Endocrinol Invest 1993;16: 37884.
  • 15
    Mori M, Naito M, Watanabe H, et al. Effects of sex difference, gonadectomy and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors. Cancer Res 1990;50: 76627.
  • 16
    Takeichi N, Ito H, Haruta R, et al. Relation between estrogen receptor and malignancy of thyroid cancer. Jpn J Cancer Res 1991;82: 1922.
  • 17
    Cancer incidence in Oman. National Cancer Registry, Non-Communicable Diseases Control Section, Directorate General of Health Affairs, Ministry of Health, Sultanate of Oman, 1997.
  • 18
    Cancer incidence report (draft). Gulf Cooperation Council Countries, Gulf Centre for Cancer Registration, Saudi Arabia, 1998.
  • 19
    Cancer incidence report. National Cancer Registry, Ministry of Health, Kingdom of Saudi Arabia, 1994– 96.
  • 20
    Breslow NE, Day NE. Statistical methods in cancer research. Vol. I. The analysis of case-control studies. Lyon, IARC: IARC Sci. Publ. No. 32, 1980.
  • 21
    El-Ghamrawi KA, Khalifa MS. Thyroid cancer in Kuwait: review of 117 cases. Br J Surg 1979;66: 13942.
  • 22
    Economic and Social Commission for Western Asia. Demographic and related socio-economic data sheets. United Nations, No. 10, 1999.
  • 23
    Al-Rashoud R, Farid S. Kuwait child health survey. Ministry of Health, Kuwait, 1991.
  • 24
    Biddinger P, Nikiforov YE. Pathologic features of thyroid tumors. In: FaginJA, ed. Thyroid cancer. USA: Kluwer Academic Publishers, 1998. 10537.
  • 25
    Franceschi S, Fassina A, Talamini R, et al. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidém Santé Publ 1990;38: 2734.
  • 26
    Levi F, Franceschi S, Gulie C, et al. Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland. Oncology 1993;50: 30915.
  • 27
    Rossing MA, Voigt LF, Wicklund KG, et al. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151: 76572.
  • 28
    Galanti MR, Lambe M, Ekbom A, et al. Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort. Cancer Causes Control 1995;6: 3744.
  • 29
    Akslen LA, Nilssen S, Kvåle G. Reproductive factors and risk of thyroid cancer. A prospective study of 63,090 women from Norway. Br J Cancer 1992;65: 7724.
  • 30
    McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 1984;120: 42335.
  • 31
    Preston-Martin S, Bernstein L, Pike MC, et al. Thyroid cancer among young women related to prior thyroid disease and pregnancy history. Br J Cancer 1987;55: 1915.
  • 32
    Ron E, Kleinerman RA, Boice JD, et al. A population-based case-control study of thyroid cancer. J Natl Cancer Inst 1987;79: 112.
  • 33
    Preston-Martin S, Jin F, Duda MJ, et al. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 1993;4: 43140.
  • 34
    Wingren G, Hatschek T, Axelson O. Determinants of papillary cancer of the thyroid. Am J Epidemiol 1993;138: 48291.
  • 35
    Hallquist A, Hardell L, Degerman A, et al. Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev 1994;3: 4818.
  • 36
    Takezaki T, Hirose K, Inoue M, et al. Risk factors of thyroid cancer among women in Tokai, Japan. J Epidemiol 1996;6: 1407.
  • 37
    Kolonel LN, Hankin JH, Wilkens LR, et al. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1990;1: 22334.
  • 38
    Galanti MR, Hansson L, Lund E, et al. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 1996;5: 42531.
  • 39
    Mack WJ, Preston-Martin S, Brenstein L, et al. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999;8: 9917.
  • 40
    Kravdal Ø, Glattre E, Haldorsen T. Positive correlation between parity and incidence of thyroid cancer: new evidence based on complete Norwegian birth cohorts. Int J Cancer 1991;49: 8316.
  • 41
    McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res 1987;47: 2925.
  • 42
    Walfish PG, Meyerson J, Provias JP, et al. Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada. J Endocrinol Invest 1992;15: 26572.
  • 43
    Shah NM, Shah MA, Al-Rahmani E, et al. Trends, patterns and correlates of contraceptive use among Kuwaitis, 1984–99. Med Principles Pract 2001;10: 3440.
  • 44
    Rossing MA, Voigt LF, Wocklund KG, et al. Use of exogenous hormones and risk of papillary thyroid cancer (Washington, US). Cancer Causes Control 1998;9: 3419.
  • 45
    Rossing MA, Cushing KL, Voigt LF, et al. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 2000;11: 4954.
  • 46
    Memon A, Moody PM, Sugathan TN, et al. Epidemiology of smoking among Kuwaiti adults: prevalence, characteristics and attitudes. Bull World Health Organ 2000;78: 130615.
  • 47
    Al-Isa AN. Prevalence of obesity among adult Kuwaitis: a cross-sectional study. Int J Obes 1995;19: 4313.